1019 related articles for article (PubMed ID: 22991139)
1. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel posttranslational modification in neuronal nitric oxide synthase by small ubiquitin-related modifier-1.
Watanabe M; Itoh K
Biochim Biophys Acta; 2011 Jul; 1814(7):900-7. PubMed ID: 21545853
[TBL] [Abstract][Full Text] [Related]
3. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
[TBL] [Abstract][Full Text] [Related]
4. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
[TBL] [Abstract][Full Text] [Related]
5. SUMOylation of FOXM1B alters its transcriptional activity on regulation of MiR-200 family and JNK1 in MCF7 human breast cancer cells.
Wang CM; Liu R; Wang L; Nascimento L; Brennan VC; Yang WH
Int J Mol Sci; 2014 Jun; 15(6):10233-51. PubMed ID: 24918286
[TBL] [Abstract][Full Text] [Related]
6. Sumoylation of CoREST modulates its function as a transcriptional repressor.
Muraoka A; Maeda A; Nakahara N; Yokota M; Nishida T; Maruyama T; Ohshima T
Biochem Biophys Res Commun; 2008 Dec; 377(4):1031-5. PubMed ID: 18854179
[TBL] [Abstract][Full Text] [Related]
7. SUMOylation can regulate the activity of ETS-like transcription factor 4.
Kaikkonen S; Makkonen H; Rytinki M; Palvimo JJ
Biochim Biophys Acta; 2010 Aug; 1799(8):555-60. PubMed ID: 20637912
[TBL] [Abstract][Full Text] [Related]
8. Biochemical characterization of SUMO-conjugating enzymes by in vitro sumoylation assays.
Eisenhardt N; Ilic D; Nagamalleswari E; Pichler A
Methods Enzymol; 2019; 618():167-185. PubMed ID: 30850051
[TBL] [Abstract][Full Text] [Related]
9. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
10. High mobility group nucleosomal binding domain 2 (HMGN2) SUMOylation by the SUMO E3 ligase PIAS1 decreases the binding affinity to nucleosome core particles.
Wu J; Kim S; Kwak MS; Jeong JB; Min HJ; Yoon HG; Ahn JH; Shin JS
J Biol Chem; 2014 Jul; 289(29):20000-11. PubMed ID: 24872413
[TBL] [Abstract][Full Text] [Related]
11. HIF-1α SUMOylation affects the stability and transcriptional activity of HIF-1α in human lens epithelial cells.
Han X; Wang XL; Li Q; Dong XX; Zhang JS; Yan QC
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1279-90. PubMed ID: 25877955
[TBL] [Abstract][Full Text] [Related]
12. Sumoylation regulates EXO1 stability and processing of DNA damage.
Bologna S; Altmannova V; Valtorta E; Koenig C; Liberali P; Gentili C; Anrather D; Ammerer G; Pelkmans L; Krejci L; Ferrari S
Cell Cycle; 2015 Aug; 14(15):2439-50. PubMed ID: 26083678
[TBL] [Abstract][Full Text] [Related]
13. Covalent small ubiquitin-like modifier (SUMO) modification of Maf1 protein controls RNA polymerase III-dependent transcription repression.
Rohira AD; Chen CY; Allen JR; Johnson DL
J Biol Chem; 2013 Jun; 288(26):19288-95. PubMed ID: 23673667
[TBL] [Abstract][Full Text] [Related]
14. SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage.
Lee SW; Lee MH; Park JH; Kang SH; Yoo HM; Ka SH; Oh YM; Jeon YJ; Chung CH
EMBO J; 2012 Nov; 31(23):4441-52. PubMed ID: 23092970
[TBL] [Abstract][Full Text] [Related]
15. The language-related transcription factor FOXP2 is post-translationally modified with small ubiquitin-like modifiers.
Estruch SB; Graham SA; Deriziotis P; Fisher SE
Sci Rep; 2016 Feb; 6():20911. PubMed ID: 26867680
[TBL] [Abstract][Full Text] [Related]
16. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
[TBL] [Abstract][Full Text] [Related]
17. Pax8 protein stability is controlled by sumoylation.
de Cristofaro T; Mascia A; Pappalardo A; D'Andrea B; Nitsch L; Zannini M
J Mol Endocrinol; 2009 Jan; 42(1):35-46. PubMed ID: 18974227
[TBL] [Abstract][Full Text] [Related]
18. SUMO: getting it on.
Anckar J; Sistonen L
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
[TBL] [Abstract][Full Text] [Related]
19. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
[TBL] [Abstract][Full Text] [Related]
20. PIASγ controls stability and facilitates SUMO-2 conjugation to CoREST family of transcriptional co-repressors.
Sáez JE; Arredondo C; Rivera C; Andrés ME
Biochem J; 2018 Apr; 475(8):1441-1454. PubMed ID: 29555846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
